1. Home
  2. BYON vs DCTH Comparison

BYON vs DCTH Comparison

Compare BYON & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYON
  • DCTH
  • Stock Information
  • Founded
  • BYON 1997
  • DCTH 1988
  • Country
  • BYON United States
  • DCTH United States
  • Employees
  • BYON 610
  • DCTH N/A
  • Industry
  • BYON Catalog/Specialty Distribution
  • DCTH Medical/Dental Instruments
  • Sector
  • BYON Consumer Discretionary
  • DCTH Health Care
  • Exchange
  • BYON Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • BYON 556.8M
  • DCTH 394.9M
  • IPO Year
  • BYON N/A
  • DCTH N/A
  • Fundamental
  • Price
  • BYON $9.47
  • DCTH $10.89
  • Analyst Decision
  • BYON Hold
  • DCTH Strong Buy
  • Analyst Count
  • BYON 8
  • DCTH 4
  • Target Price
  • BYON $10.33
  • DCTH $24.50
  • AVG Volume (30 Days)
  • BYON 2.9M
  • DCTH 825.0K
  • Earning Date
  • BYON 10-23-2025
  • DCTH 08-06-2025
  • Dividend Yield
  • BYON N/A
  • DCTH N/A
  • EPS Growth
  • BYON N/A
  • DCTH N/A
  • EPS
  • BYON N/A
  • DCTH 0.06
  • Revenue
  • BYON $1,128,578,000.00
  • DCTH $70,240,000.00
  • Revenue This Year
  • BYON N/A
  • DCTH $160.46
  • Revenue Next Year
  • BYON $13.21
  • DCTH $42.87
  • P/E Ratio
  • BYON N/A
  • DCTH $195.18
  • Revenue Growth
  • BYON N/A
  • DCTH 491.35
  • 52 Week Low
  • BYON $3.54
  • DCTH $8.08
  • 52 Week High
  • BYON $12.24
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • BYON 56.15
  • DCTH 48.16
  • Support Level
  • BYON $8.65
  • DCTH $10.06
  • Resistance Level
  • BYON $10.03
  • DCTH $10.81
  • Average True Range (ATR)
  • BYON 0.59
  • DCTH 0.71
  • MACD
  • BYON 0.03
  • DCTH 0.13
  • Stochastic Oscillator
  • BYON 74.77
  • DCTH 28.57

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad number of products, including furniture, decor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: